TRC-EID

E-BOOK

The immune system is complex and involves many genes, including those that encode cytokines known as interferons (IFNs). Individuals that lack specific IFNs can be more susceptible to infectious diseases. Furthermore, the autoantibody system dampens IFN response to prevent damage from pathogen-induced inflammation. Two studies now examine the likelihood that genetics affects the risk of severe coronavirus disease 2019 (COVID-19) through components of this system (see the Perspective by Beck and Aksentijevich). Q. Zhang et al. used a candidate gene approach and identified patients with severe COVID-19 who have mutations in genes involved in the regulation of type I and III IFN immunity. They found enrichment of these genes in patients and conclude that genetics may determine the clinical course of the infection. Bastard et al. identified individuals with high titers of neutralizing autoantibodies against type I IFN-α2 and IFN-ω in about 10% of patients with severe COVID-19 pneumonia. These autoantibodies were not found either in infected people who were asymptomatic or had milder phenotype or in healthy individuals. Together, these studies identify a means by which individuals at highest risk of life-threatening COVID-19 can be identified.
BY :
TRC Admin
Views :
46
TYPE :
pdf
DOWNLOAD
  • 918
  • 1298
  • 25
  • 1
  • 0.06
  • true
  • false
  • true
  • true
  • false
  • true
  • false
  • https://trceid.org//upload/ebo/file/file-20212701-1611711925-510-Thai-197.pdf
  • 1
  • double
CLICK TO VERIFY: This site uses a GlobalSign SSL Certificate to secure your personal information.